DWM
TEVA icon

Destination Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Destination Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25
Closed – – 740
2019
Q1 		$0 Buy
+25
New +$441 ﹤0.01% 720
2018
Q3 		– Sell
-300
Closed -$7K – 761
2018
Q2 		$7K Buy
+300
New +$6.12K ﹤0.01% 422

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Destination Wealth Management's TEVA Position: Q2 2019 in Review

Destination Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2019, closing a stake of 25 shares.

Destination Wealth Management first reported a position in TEVA in Q2 2018 and held it in 2 quarters. The position peaked at $7K in Q2 2018. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

  • Destination Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2019 after selling out during the quarter.
  • Destination Wealth Management sold 25 Teva Pharmaceutical Industries Limited shares in Q2 2019.
  • Destination Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2018 and held it in 2 quarters.
  • Destination Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $7K in Q2 2018.
  • 452 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2019.

Based on Destination Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.